Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rivaroxaban for Acute PVT in HCV Cirrhosis
NCT03193502Phase 3Unknown
- Start
- May 2014
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of rivaroxaban in portal vein thrombosis (PVT). Primary endpoint: Number of patients with recanalized portal vein at 6 months. Status: unknown.
02
Drugs
rivaroxaban
03
Conditions
portal vein thrombosis (PVT)
Beyond the preview
Go deeper on NCT03193502.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03193502.